Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1389 of 6351
-
Ear zaps may soothe painful side effect of breast cancer drugs
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether transcutaneous auricular vagus nerve stimulation, also called taVNS, can help relieve aromatase inhibitor-related joint and muscle pain in adult women with hormone receptor-positive breast cancer. The main questions this study …
Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New trial: can hormone pills boost targeted cancer therapy?
Disease control Recruiting nowThe goal of this study is to determine whether the addition of Androgen Deprivation Therapy (ADT) utilizing the study drug ELIGARD® to Recurrence- Directed Therapy (RDT) improves progression-free survival (PFS) compared to RDT alone in patients with early radio-recurrent oligo-me…
Phase 2 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a 5-Session therapy help teens with PTSD?
Symptom relief OngoingWritten Exposure Therapy (WET) is a five-session mental health therapy for posttraumatic stress disorder (PTSD). Research shows that it works as well as longer treatments for PTSD among people over 18, even though it requires fewer sessions than other PTSD therapies. However, WET…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Breast cancer trial lets early response guide treatment switch
Disease control Recruiting nowThis prospective, response-adapted phase II study evaluates the efficacy and safety of neoadjuvant culmerciclib in combination with aromatase inhibitors in patients with highly proliferative ER-positive/HER2-negative breast cancer. All patients initially receive induction treatme…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Chatbot vs. HPV: 18,000 parents test digital nudge for teen vaccination
Prevention Not yet recruitingThis is an interventional study targeting parents of junior high school girls. The primary objective of the study is to evaluate the effectiveness of a vaccine chatbot in improving HPV vaccination rates among parents' junior high school girls. The secondary objectives are to eval…
Sponsor: Xiamen University • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Buddy system: new study tests friend talks to curb Booze-Fueled assaults
Prevention Recruiting nowThis Phase 2 trial will to examine the efficacy of a brief dyad-based motivational interview (PAIRS MI) delivered to friend dyads with an active treatment-as-usual condition, and a 1-year follow-up.
Sponsor: State University of New York at Buffalo • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
New antibody drug aims to ease lung blood pressure
Disease control Recruiting nowThis study is researching an experimental drug called REGN13335. The study is focused on participants with Pulmonary Arterial Hypertension (PAH). The aim of the study is to see how safe and effective REGN13335 is in participants with PAH who are taking other PAH medicines. The s…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
Knowledge-focused Recruiting nowThe purpose of this study is to better understand the natural history, clinical outcomes, and biological features of Gaucher disease in patients receiving standard medical care
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Peer support may lift the cloud of loneliness for older gay men with HIV
Symptom relief Recruiting nowOlder gay and bisexual men living with HIV (OGBMLH) are more likely to experience depression and loneliness, which can lead to negative health outcomes. This mixed-methods research study will assess the feasibility and acceptability of the Bridge to Belonging (B2B) intervention. …
Sponsor: Fenway Community Health • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Firefighters' diet study aims to cut cancer risk with station-based nutrition program
Prevention Recruiting nowFirefighters may be at increased risk of poor dietary habits due to nature of shift work, extended duty periods, and reliance on food available within fire station environments. Irregular working patterns and limited access to healthy food options during shifts can contribute to …
Sponsor: Avon Fire and Rescue Service • Aim: Prevention
Last updated Aug 23, 2026 00:00 UTC
-
Teaching the brain about pain may boost exercise benefits for chronic pain sufferers
Symptom relief By invitation onlyChronic pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, with a high prevalence in Spain (25.9%) and an average duration of 6.83 years, highlighting its significant health and social impact. Among its manifestations, chroni…
Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New combo therapy aims to stop liver cancer in its tracks
Disease control Recruiting nowThe study investigates the adjuvant SBRT following TACE in early and intermediate stages HCC not amenable for surgical resection.
Sponsor: RWTH Aachen University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for twin moms: drug may cut dangerous bleeding after childbirth
Prevention Recruiting nowThe goal of this clinical trial is to learn if the drug carbetocin works better than standard care to prevent heavy bleeding after childbirth in people carrying twin pregnancies. Heavy bleeding after delivery, also called postpartum hemorrhage, is more common after twin births an…
Phase 4 • Sponsor: Sheba Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Morning or afternoon? timing of immunotherapy infusion may affect esophageal cancer outcomes
Disease control Recruiting nowThis is a prospective, multi-cohort, exploratory clinical study designed to evaluate the efficacy and safety of neoadjuvant adebrelimab combined with chemotherapy in patients with resectable locally advanced thoracic esophageal squamous cell carcinoma (ESCC), with a particular fo…
Phase 2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Stoma-Free surgery for rectal cancer? new trial tests safety
Disease control Recruiting nowThe purpose of this multicenter randomized non-inferiority trial is to evaluate the safety of low anterior resection for rectal cancer performed with versus without a diverting stoma in patients with a low predicted risk of colorectal anastomotic leakage. The primary objective i…
Sponsor: ANO Scientific and Practical Club for the Development of Modern Medical Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Electric eye therapy: can a home device slow blindness?
Disease control Recruiting nowGeographic atrophy (GA) is a progressive eye disease that causes the degeneration of the retinal cells, particularly in the macula, leading to vision loss. The goal of this pilot study is to evaluate the safety and the effectiveness of transcorneal electrical stimulation (TES) th…
Sponsor: Okuvision GmbH • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Diabetes drug could fight rare brain cancer in kids
Disease control Recruiting nowThis is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma.
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New digital toolkit aims to transform care for millions with multiple chronic diseases
Disease control Not yet recruitingMultiple Long-Term Conditions (MLTC), defined as the coexistence of two or more chronic conditions, is increasingly prevalent in India. Despite this, the healthcare system remains largely focused on single-disease management, underscoring the urgent need for integrated, patient-c…
Sponsor: Centre for Chronic Disease Control, India • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Scientists probe Virus-Cancer link to unlock better treatments
Knowledge-focused Recruiting nowThe presence or absence of viruses affects the characteristics of cancer, the response to anti-cancer treatments, and the prognosis of the disease. A cancerous tumor consists of cancerous cells as well as a variety of non-cancerous cells and molecules, collectively known as the t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New triple therapy targets stomach cancer after immunotherapy fails
Disease control Not yet recruitingThis is a prospective, single-arm, investigator-initiated phase II clinical study. The study evaluates the efficacy and safety of retlirafusp alfa (a PD-L1/TGF-βRII bifunctional fusion protein) combined with apatinib (a VEGFR-2 tyrosine kinase inhibitor) and nab-paclitaxel in pat…
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC